Description
GLP3 also known as Retatrutide or Reta, has gained significant attention because of its unique three-target approach. Unlike traditional GLP-1 products, Reta interacts with three hormone receptors: GLP-1, GIP, and glucagon.
This combination stands out because of its three-part approach:
- GLP-1: Connected to appetite and blood sugar regulation
- GIP: Connected to metabolism and insulin response
- Glucagon: Connected to energy use and metabolism
Together, these targets are what make GLP3 different from traditional single-pathway GLP-1 products.
Research Use Only Disclaimer
RESEARCH USE ONLY
These products are sold strictly for laboratory and research purposes only. They are not intended for human or veterinary use, consumption, or for the diagnosis, treatment, cure, or prevention of any disease.
These products are not prescription medications and are not provided through a licensed healthcare provider or physician review. They have not been evaluated by the Food and Drug Administration (FDA).
